Asian Multicenter Prospective Study of ctDNA Sequencing

Active, not recruitingOBSERVATIONAL
Enrollment

506

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Cervical CancerOvarian Clear Cell CarcinomaNasopharyngeal CarcinomaOvarian CancerEndometrial CancerTriple Negative Breast Cancer
Interventions
GENETIC

NGS analysis of ctDNA

Diagnostic Test: plasma circulating tumor DNA

Trial Locations (19)

1102

St. Luke's Medical Center, Manila

10300

Vajira Hospital, Bangkok

10330

Chulalongkorn University, Bangkok

10400

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok

Phramongkutklao Hospital, Bangkok

10700

Mahidol University by Faculty of Medicine, Siriraj Hospital, Bangkok

50200

Chiang Mai University, Chiang Mai

50586

Hospital Kuala Lumpur, Kuala Lumpur

59100

University Malaya Medicine Centre, Kuala Lumpur

62250

Institut Kanser Negara, Putrajaya

90110

Songklanagarind Hospital, Songkhla

93586

Sarawak General Hospital, Kuching

100225

National Taiwan University Hospital, Taipei

119228

National University Hopital, Kent Ridge

168582

National Cancer Centre of Singapore, Bukit Merah

104-0045

National Cancer Center Hospital, Tokyo

03722

Severance Hospital, Yonsei University Health System, Seoul

Unknown

K Hospital, Hanoi

Ho Chi Minh City Oncology Hospital, Ho Chi Minh City

All Listed Sponsors
lead

National Cancer Center, Japan

OTHER_GOV